ProCE Banner Activity

Evolving Treatment Paradigm in Advanced Non-Small-Cell Lung Cancer

Slideset Download
Download these slides providing the latest on the rapidly evolving treatment paradigm for patients with advanced NSCLC

Released: June 23, 2020

Expiration: June 22, 2021

Share

Faculty

Matthew Gubens

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Celgene

Loxo Oncology subsidiary of Eli Lilly

Partners

GRACE

ProCE Banner

Faculty Disclosure

Primary Author

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California

Matthew Gubens, MD, MS, has disclosed that he has received consulting fees from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, BeyondSpring, Inivata, and Takeda and funds for research support from Celgene, Merck, Novartis, OncoMed, and Roche.